Who backs Star Therapeutics?
19 investors| Investor | Type |
|---|---|
| Viking Global Investors | Asset manager |
| RA Capital Management | Asset manager |
| OrbiMed | Growth equity |
| Qatar Investment Authority | Asset manager |
| Catalio Capital Management | Venture capital |
| Cormorant Asset Management | Venture capital |
| Frazier Healthcare Partners | Venture capital |
| Redmile Group | PE / buyout |
| Soleus Capital | PE / buyout |
| New Leaf Venture | Venture capital |
| + 9 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Star Therapeutics investors
19 investors are on record for Star Therapeutics, including Viking Global Investors, RA Capital Management, OrbiMed and Qatar Investment Authority. By type, the record holds 5 venture capital firms, 3 asset managers and 3 private equity firms. The Series D in Sep 2025 drew 17 investors.
Free account
More of Star Therapeutics with a free account
- ·The complete investor list: 19 names
- ·Watch Star Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 19 firms already write checks for companies like Star Therapeutics in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View